Brief: Hikma Expands Agreement With AFT Pharmaceuticals For Commercialisation Of Combogesic®
Feb 12 (Reuters) - HIKMA HIK.L :
* EXPANDS AGREEMENT WITH AFT PHARMACEUTICALS FOR
COMMERCIALISATION
OF INJECTABLE PAIN MEDICATION COMBOGESIC® IN SAUDI, JORDANIAN,
IRAQI MARKETS
Source text for Eikon: ID:
Further company coverage: AFT.NZ
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV